Alaunos Therapeutics Inc TCRT:NASDAQ

Last Price$1.23NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change+0.13(11.82%)
Bid (Size)$1.17 (1)
Ask (Size)$1.21 (2)
Day Low / High$1.03 - 1.27
Volume18.7 K

Sector Update: Health Care Stocks Recoup Portion of Prior Losses

3:52PM ET 9/28/2021 MT Newswires
Health care stocks were ending well above their intra-day lows this afternoon, with the NYSE Health Care Index falling 1.1% in late trade while the SPDR Health Care Select Sector ETF (XLV) also was down 1.3%.

The Nasdaq Biotechnology index was sinking 2.4%.

In company news, Teva Pharmaceutical Industries (TEVA) climbed 4.9% on Tuesday after the drugmaker said it agreed to pay $15 million to the state of Louisiana over an 18-year period to settle opioid-related claims, subject to confirmation by state officials before Nov 2. The company also agreed to donate $3 million of medicines to the state.

Sonoma Pharmaceuticals (SNOA) raced over 30% higher after beginning over-the-counter sales in the US of its Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser and its MucoClyns decontamination solution in Europe through Amazon.com (AMZN).

Among decliners, Ziopharm (ZIOP) fell more than 10% after disclosing plans to eliminate 60 positions, representing roughly half of its current workforce, which it said will keep the immuno-oncology company in business through the first half of 2023.

Ensysce Biosciences (ENSC) also dropped 11% after the specialty drugmaker late Monday said it had secured $15 million in new funding through a private placement of 5% senior convertible notes with an initial conversion rate of $5.87 per share. Investors also received 5-year warrants to buy up to 1.08 million Ensysce common shares exercisable at $7.63 per share.